spirapril
Sign in to saveAlso known as Renormax®, SCH-33844
Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension. It belongs to dicarboxy group of ACE inhibitors.
Research
147 papers- Spirapril. A preliminary review of its pharmacology and therapeutic efficacy in the treatment of hypertension.Drugs · 1995
- Efficacy and safety of spirapril in mild-to-moderate hypertension.Journal of cardiovascular pharmacology · 1999
- Angiotensin-converting enzyme inhibitor induced cough compared with placebo, and other antihypertensives: A systematic review, and network meta-analysis.Journal of clinical hypertension (Greenwich, Conn.) · 2023
- Comparison of efficacy of spirapril and enalapril in control of mild-to-moderate hypertension.Cardiovascular drugs and therapy · 1997
- ACE inhibition in chronic renal failure and in the treatment of diabetic nephropathy: focus on spirapril.Journal of cardiovascular pharmacology · 1999
via PubMed
Wikidata facts
- Subclass of
- chemical compound
- Mass
- 466.16
- Has use
- medication
Show 6 more facts
- chemical formula
- C₂₂H₃₀N₂O₅S₂
- canonical SMILES
- CCOC(=O)C(CCC1=CC=CC=C1)NC(C)C(=O)N2CC3(CC2C(=O)O)SCCS3
- isomeric SMILES
- CCOC(=O)[C@H](CCC1=CC=CC=C1)N[C@@H](C)C(=O)N2CC3(C[C@H]2C(=O)O)SCCS3
- defined daily dose
- 6
- Commons category
- Spirapril
- subject has role
- ACE inhibitor
Sources (3)
via Wikidata · CC0
~1 min read
Encyclopedic overview
3 sectionsContents
- Chemistry
- References
- External links
Spirapril, sold under the brand name Renormax among others, is an ACE inhibitor antihypertensive drug used to treat hypertension. It belongs to dicarboxy group of ACE inhibitors.
It was patented in 1980 and approved for medical use in 1995.
Excerpted from Wikipedia’s “spirapril” article, available under the CC BY-SA 4.0 licence.